News | Mammography | March 31, 2017

New data analysis shows nearly 275,000 breast cancer deaths have been averted since 1990, attributed to increased mammographic screening and improved therapies

breast cancer deaths, mammography screening, ACR, yearly decline

March 31, 2017 — A recent analysis of newly added 2014 data to the National Cancer Institute SEER database by R. Edward Hendrick, Ph.D., shows that the breast cancer death rate has now fallen 38 percent since 1990. This downward trend follows the increased use of mammography screening beginning in the mid-1980s. This decline amounts to 274,765 breast cancer deaths averted since 1990 — including 22,054 in 2014 alone.  

In 1990, 73.8 women per 100,000 women died of breast cancer. The newly-added 2014 SEER data shows that figure has dropped to 45.9 breast cancer deaths per 100,000 women. Prior to 1990, the breast cancer death rate had remained virtually unchanged since death rates were first recorded by SEER in 1969.

Regular mammography screening and improved therapies are undoubtedly responsible for the decline in breast cancer deaths, according to the research authors. Mammography can detect cancer early when it is most treatable and can be treated less invasively. This also helps preserve quality of life.

study published in Cancer showed that more than 70 percent of the women who died from breast cancer in their 40's at Harvard teaching hospitals were among the 20 percent of women who were not being screened. A study in the British Medical Journal shows that early detection of breast cancer — as with mammography — significantly improves breast cancer survival.

Major American medical organizations with expertise in breast cancer care, including the American Congress of Obstetricians and Gynecologists (ACOG), American College of Radiology (ACR) and Society of Breast Imaging (SBI) continue to recommend that women start getting annual mammograms at age 40.

For more information: www.mammographysaveslives.org


Related Content

News | FDA

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
News | Breast Imaging

May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...

Time May 10, 2024
arrow
News | Radiology Business

May 6, 2024 — ScreenPoint Medical’s Board of Directors has announced the appointment of Peter Kroese as the new Chief ...

Time May 06, 2024
arrow
News | Mammography

May 6, 2024 — Enable Me, a VELA Medical company, cited major new research by Siemens Healthineers entitled, “The future ...

Time May 06, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
arrow
Feature | Breast Density | By Robert L. Bard, MD

Decades since the advent of breast scanning technology, innovations in noninvasive diagnostic imaging provide new ...

Time May 03, 2024
arrow
News | Breast Imaging

May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...

Time May 01, 2024
arrow
News | Breast Imaging

May 1, 2024 — The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast ...

Time May 01, 2024
arrow
News | Breast Imaging

May 1, 2024 — After the issuance of updated breast screening recommendations by the U.S. Preventive Services Task Force ...

Time May 01, 2024
arrow
Subscribe Now